Antimicrobial activity of antibiotic-treated amniotic membrane: An in vitro study

Cornea

Volumn 25, Issue 4, 2006, Pages 428-431

  Mencucci, Rita ^a,b   Menchini, Ugo ^a   Dei, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Eye Clinic   (Italy)

Author keywords

Amniotic membrane transplantation; Antibiotic treated amniotic membrane

Indexed keywords

ANTIBIOTIC AGENT; NETILMICIN; ANTIINFECTIVE AGENT; DRUG CARRIER;

AGAR GEL DIFFUSION; AMNION; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG ACTIVITY; DRUG RELEASE; DRUG UPTAKE; ELUTION; FRAGMENTATION REACTION; GROWTH INHIBITION; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; BACTERIAL COUNT; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY;

AMNION; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; HUMANS; NETILMICIN; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33745018850     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000214207.06952.23     Document Type: Article

References (29)

1. deRotth A. Plastic repair of conjunctival defects with fetal membrane. Arch Ophthalmol. 1940;23:522-525.
2. Sorsby A, Symons HM. Amniotic membrane grafts in caustic burns of the eye. Br J Ophthalmol. 1946;30:337-345.
3. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473-484.
4. Lee SH, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-312.
5. Sippel KC, Ma JJK, Stephen Foster C. Amniotic membrane surgery. Curr Opinion Ophthalmol. 2001;12:269-281.
6. John T. Human amniotic membrane transplantation: past, present, and future. Ophthalmol Clin North Am. 2003;16:43-63 vi.
7. Shimmura S, Shimazaki J, Ohashi Y, et al. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408-413.
8. Kim JS, Kim JC, Hahn TW, et al. Amniotic membrane transplantation in infectious corneal ulcers. Cornea. 2001;20:720-726.
9. Gris O, Lopez-Navidad A, Caballero F, et al. Amniotic membrane transplantation for ocular surface pathology: long-term survey. Transplant Proc. 2003;35:2031-2035.
10. Tseng SCG, Espana EM, Kawakita T, et al. How does amniotic membrane work? The Ocular Surface. 2004;2:177-187.
11. Dua HS, Gomes JA, King AJ, et al. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49:51-77.
12. Willoughby CE, Batterbury M, Kaye SB, et al. Collagen corneal shields. Survey Ophthalmol. 2002;47:174-182.
13. Darouiche RO, Fowler VG Jr, Adal K, et al. Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin. Antimicrob Agents Chemoter. 2002;46:543-545.
14. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83:748-752.
15. Baum J. Amniotic membrane transplantation. Why is it effective? Cornea. 2002;21:339-341.
16. Akle CA, Adinolfi M, Welsh KI. Immunogenicity of human amniotic epithelial cells after transplantation in human volunteers. Lancet. 1981;2:1003-1005.
17. Tseng SC. Amniotic membrane transplantation for persistent corneal epithelial defect. Br J Ophthalmol. 2001;85:1400-1401.
18. Tseng SC. Amniotic membrane transplantation for ocular surface reconstruction. Biosci Rep. 2001;21:481-489.
19. Solomon A, Meller D, Prabhasawat P, et al. Amniotic membrane grafts for nontraumatic coneal perforations, descemetoceles, and deep ulcers. Ophthalmology. 2002;109:694-703.
20. Heiligenhaus A, Li H, Hernandez Galindo EE, et al. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation. Br J Ophthalmol. 2003;87:1215-1219.
21. Dorigo MT, De Natale R, Miglioli PA. Collagen shields delivery of netilmicin: a study of ocular pharmacokinetics. Chemotherapy. 1995;41:1-4.
22. Bonfiglio G, Scuderi AC, Russo G. Netilmicin: in vitro activity, time-kill evaluation and postantibiotic effect on microorganisms isolated from ocular infections. Chemotherapy. 2001;47:117-122.
23. Scuderi AC, Paladino GM, Marino C, et al. In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells. Cornea. 2003;22:468-472.
24. Talmi YP, Sigler L, Inge E, et al. Antibacterial properties of human amniotic membranes. Placenta. 1991;12:285-288.
25. Kamal JD, Pfaller MA, Rempe LE, et al. Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA. 1991;265:2364-2368.
26. Raad I, Darouiche R, Hachem R, et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother. 1995;39:2397-2400.
27. Echanove JA, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol. 2003;24:916-925.
28. Eveillard M, Mertl P, Tramier B, et al. Effectiveness of gentamicin-impregnated cement in the prevention of deep wound infection after primary total knee arthroplasty. Infect Control Hosp Epidemiol. 2003;24:778-780.
29. Friedberg ML, Pleyer U, Mondino BJ. Device drug delivery to the eye. Ophthalmology. 1991;98:725-732.